Thu, May 23, 2013, 2:08 AM EDT - U.S. Markets open in 7 hrs 22 mins
Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO™, in Europe following EMA approval before the end of 2012.
Unfortunately for ISIS the EMA deadline has already passed and they didn't get it. It bodes well for AEGR though.